2026 witnesses a comprehensive paradigm shift in global medicine, with the medical model gradually transforming from the traditional “disease-centered” passive
New drug research and development is characterized by long cycle, high cost and high risk, which makes it difficult for
Cardiorenal metabolic diseases including cardiovascular diseases, diabetic nephropathy and lipid metabolism disorders are the leading causes of global chronic disease
Global medical development is undergoing a profound structural change in 2026, with health equity officially moving from a marginal social
Rare diseases, with low incidence and complex pathogenesis, have long been known as “intractable diseases” in medicine. Most rare diseases
